The protease cathepsin L regulates Th17 cell differentiation

Harrington, 2005, Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat. Immunol., 6, 1123, 10.1038/ni1254 Park, 2005, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nat. Immunol., 6, 1133, 10.1038/ni1261 Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753 Mangan, 2006, Transforming growth factor-beta induces development of the T(H)17 lineage, Nature, 441, 231, 10.1038/nature04754 Zhou, 2007, IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways, Nat. Immunol., 8, 967, 10.1038/ni1488 Durant, 2010, Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis, Immunity, 32, 605, 10.1016/j.immuni.2010.05.003 Ivanov, 2006, The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121, 10.1016/j.cell.2006.07.035 McGeachy, 2009, The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo, Nat. Immunol., 10, 314, 10.1038/ni.1698 Ciofani, 2012, A validated regulatory network for Th17 cell specification, Cell, 151, 289, 10.1016/j.cell.2012.09.016 Yosef, 2013, Dynamic regulatory network controlling TH17 cell differentiation, Nature, 496, 461, 10.1038/nature11981 Gong, 2011, Critical role of serpinB1 in regulating inflammatory responses in pulmonary influenza infection, J. Infect. Dis., 204, 592, 10.1093/infdis/jir352 Zhao, 2014, SerpinB1 regulates homeostatic expansion of IL-17+ gammadelta and CD4+ Th17 cells, J. Leukoc. Biol., 95, 521, 10.1189/jlb.0613331 Benarafa, 2007, The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection, J. Exp. Med., 204, 1901, 10.1084/jem.20070494 Buhling, 2011, Gene targeting of the cysteine peptidase cathepsin H impairs lung surfactant in mice, PloS one, 6, e26247, 10.1371/journal.pone.0026247 Lee, 2012, Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain, Bioorg. Med. Chem. Lett., 22, 1340, 10.1016/j.bmcl.2011.12.079 Greenbaum, 2000, Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools, Chem. Biol., 7, 569, 10.1016/S1074-5521(00)00014-4 Shi, 2000, Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages, J. Exp. Med., 191, 1177, 10.1084/jem.191.7.1177 Zhou, 2008, TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function, Nature, 453, 236, 10.1038/nature06878 Barrett, 1982, L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L, Biochem. J., 201, 189, 10.1042/bj2010189 Cooley, 2001, The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites, Biochemistry, 40, 15762, 10.1021/bi0113925 Silverman, 2001, The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature, J. Biol. Chem., 276, 33293, 10.1074/jbc.R100016200 Reiser, 2010, Specialized roles for cysteine cathepsins in health and disease, J. Clin. Invest., 120, 3421, 10.1172/JCI42918 Gettins, 2002, Serpin structure, mechanism, and function, Chem. Rev., 102, 4751, 10.1021/cr010170+ Nakagawa, 1999, The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation, Immunol. Rev., 172, 121, 10.1111/j.1600-065X.1999.tb01361.x Drake, 1996, Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts, J. Biol. Chem., 271, 12511, 10.1074/jbc.271.21.12511 Katunuma, 1999, Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo, FEBS Lett., 458, 6, 10.1016/S0014-5793(99)01107-2 Yasuma, 1998, Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption, J. Med. Chem., 41, 4301, 10.1021/jm9803065 Liszewski, 2013, Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation, Immunity, 39, 1143, 10.1016/j.immuni.2013.10.018 Tuomela, 2012, Identification of early gene expression changes during human Th17 cell differentiation, Blood, 119, e151, 10.1182/blood-2012-01-407528 Shirahama-Noda, 2003, Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice, J. Biol. Chem., 278, 33194, 10.1074/jbc.M302742200 Maehr, 2005, Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice, J. Immunol., 174, 7066, 10.4049/jimmunol.174.11.7066